194 related articles for article (PubMed ID: 15693726)
21. [Economic aspects of drug-resistant epilepsy].
Owczarek K; Jedrzejczak J
Neurol Neurochir Pol; 2001; 35(2):309-18. PubMed ID: 11599228
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
[TBL] [Abstract][Full Text] [Related]
23. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of epilepsy in India.
Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B
Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893
[TBL] [Abstract][Full Text] [Related]
25. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries.
Ip Q; Malone DC; Chong J; Harris RB; Labiner DM
Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554
[TBL] [Abstract][Full Text] [Related]
26. Treatment-Related Costs of Childhood Epilepsy in Mainland China: A Preliminary Study in a Tertiary Pediatric Epilepsy Center.
Sang T; Xiang T; Zhu SN; Gao JY; Jiang YW; Wu Y
J Child Neurol; 2019 Feb; 34(2):68-73. PubMed ID: 30484357
[TBL] [Abstract][Full Text] [Related]
27. Cost evaluations in epilepsy: an update.
Langfitt JT
Epilepsia; 2000; 41 Suppl 2():S62-8. PubMed ID: 10885741
[TBL] [Abstract][Full Text] [Related]
28. Estimated cost of inpatient admissions and outpatient appointments for a population with epilepsy: a record linkage study.
Morgan CL; Kerr MP
Epilepsia; 2004 Jul; 45(7):849-54. PubMed ID: 15230712
[TBL] [Abstract][Full Text] [Related]
29. [Social and economic aspects of administration of new antiepileptic drugs].
Dławichowska E; Owczarek K; Fiszer U
Neurol Neurochir Pol; 2001; 35(2):245-52. PubMed ID: 11599223
[TBL] [Abstract][Full Text] [Related]
30. Side-effects of antiepileptic drugs: the economic burden.
de Kinderen RJ; Evers SM; Rinkens R; Postulart D; Vader CI; Majoie MH; Aldenkamp AP
Seizure; 2014 Mar; 23(3):184-90. PubMed ID: 24315662
[TBL] [Abstract][Full Text] [Related]
31. Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).
Berto P; Tinuper P; Viaggi S
Pharmacoeconomics; 2000 Feb; 17(2):197-208. PubMed ID: 10947342
[TBL] [Abstract][Full Text] [Related]
32. Health care charges for youth with newly diagnosed epilepsy.
Ryan JL; McGrady ME; Guilfoyle SM; Junger K; Arnett AD; Modi AC
Neurology; 2015 Aug; 85(6):490-7. PubMed ID: 26163432
[TBL] [Abstract][Full Text] [Related]
33. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
[TBL] [Abstract][Full Text] [Related]
35. The economic burden of epilepsy in Bhutan.
Wibecan L; Fink G; Tshering L; Bruno V; Patenaude B; Nirola DK; Dorji C; Dema U; Pokhrel D; Mateen FJ;
Trop Med Int Health; 2018 Apr; 23(4):342-358. PubMed ID: 29369457
[TBL] [Abstract][Full Text] [Related]
36. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
37. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
Camp C; Smithson WH; Bunker M; Burke T; Hughes D
Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
[TBL] [Abstract][Full Text] [Related]
38. [Epilepsy in adults: a costs-of-illness study].
Vlasov PK; Orekhova NV; Filatova NV; Leonova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):44-7. PubMed ID: 20873473
[TBL] [Abstract][Full Text] [Related]
39. Economic cost of treatment of childhood epilepsy in Enugu, southeast Nigeria.
Ughasoro MD; Onwujekwe OE; Ojinnaka NC
Int J Technol Assess Health Care; 2014 Oct; 30(4):469-74. PubMed ID: 25425239
[TBL] [Abstract][Full Text] [Related]
40. The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow.
Guekht A; Mizinova M; Kaimovsky I; Danilenko O; Bianchi E; Beghi E
Epilepsy Behav; 2016 Nov; 64(Pt A):122-126. PubMed ID: 27736658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
